1.Cemented total-knee arthroplasty in rheumatoid arthritis patients aged under 60 years
Fan YU ; Wang ZI ; Weng XI-SHENG ; Liang JIN-QIAN ; Lin JIN ; Jin JIN ; Qian WEN-WEI ; Qiu GUI-XING
Chinese Medical Journal 2019;132(22):2760-2761
2.Dendrobium officinale cliff epiphytic cultivation method.
Jin-ping SI ; Zi-yun CHEN ; Jing-jing LU ; Yu-qiu ZHU ; Guo-jian CAI ; Bing-rong HUANG ; Kun-yi ZHANG ; Chuan-gao JIN
China Journal of Chinese Materia Medica 2015;40(12):2289-2292
To solve the issues of costly planting of facility cultivation method and inferior efficacy than wild herbs of Dendrobium officinale, the cliff epiphytic cultivation method was studied. To research the growth, agronomic traits, yield, polysaccharide and alcohol-soluble extract contents were measured on the D. officinale from different water regulation and cliff slope gradients treatments. The results showed that D. officinale epiphytic at 85 degrees-90 degrees cliff and sprayed water 1-2 h x d(-1) at the growing season can get better growth and obtain high yield, and the morphology has no different from wild cliff D. officinale, even in the environments without shade. The contents of polysaccharide and alcohol-soluble extract are closely related to the physiological ages, but significantly higher than the facility cultivation. It is possible that environmental stresses benefit the accumulation of polysaccharides, alcohol-soluble extract and other efficient ingredients.
Agriculture
;
methods
;
Dendrobium
;
chemistry
;
growth & development
;
Drugs, Chinese Herbal
;
analysis
;
Polysaccharides
;
analysis
;
Water
;
analysis
3.The different characteristics of ABL kinase domain mutation in the Chinese Han nationality imatinib resistant Philadelphia chromosome-positive acute lymphoblastic leukemia and chronic myeloid leukemia.
Hong-jie SHEN ; Jun HE ; Qiao-cheng QIU ; Jian-nong CEN ; Jin-lan PAN ; Li YAO ; Zi-xuan DING ; Yan CHEN ; Zi-xing CHEN
Chinese Journal of Hematology 2013;34(1):21-25
OBJECTIVETo identify the distribution and differentiation of ABL kinase domain mutation in the Chinese Han nationality imatinib resistant chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+)ALL).
METHODSBone marrow or peripheral blood samples of 112 imatinib resistant CML patients and 21 Ph(+)ALL patients were obtained from the first affiliated hospital of Soochow university according to local law. Total RNA was extracted from the mononuclear cells using a TRIzol reagent. ABL kinase domain (KD) mutation was detected by direct sequencing.
RESULTSOf the 112 imatinib resistant CML patients, 54.46%(61 cases) had ABL KD mutation. Twenty-three mutants were identified in 20 amino acid sites and 23.21% (26 cases) ABL KD mutations were in P-loop region. ABL KD mutations were also detected in 71.43% (15 cases) imatinib resistant Ph(+)ALL patients, with 10 mutations in 8 amino acid sites. The most frequent mutation was T315I (28.57%), followed by E255K/V (19.05%) and Y253F/H (14.29%). The frequency of T315I was much higher in imatinib resistant Ph(+) ALL than that in imatinib resistant CML (P = 0.001). Ph(+)ALL with additional chromosomal aberrations also had a higher rate of ABL KD mutation than that of CML (P = 0.010). Ph(+)ALL gained ABL KD mutation faster than CML (P < 0.010).
CONCLUSIONChinese imatinib resistant CML and Ph(+)ALL patients had different characteristics in ABL KD mutation. The rate of ABL KD mutation in Ph(+)ALL with additional chromosomal aberrations was much higher than that of CML with additional chromosomal aberrations.
Adolescent ; Adult ; Aged ; Asian Continental Ancestry Group ; genetics ; Benzamides ; pharmacology ; Chromosome Aberrations ; Drug Resistance, Neoplasm ; genetics ; Female ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive ; genetics ; Middle Aged ; Mutation ; Philadelphia Chromosome ; Piperazines ; pharmacology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; genetics ; Protein-Tyrosine Kinases ; genetics ; Proto-Oncogene Proteins c-abl ; genetics ; Pyrimidines ; pharmacology ; Young Adult
4.Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer.
Jin PENG ; Sheng JIAN-QIU ; Zhang YING-HUI ; Li AI-QIN ; Wu ZI-TAO ; Li SHI-RONG
Chinese Medical Sciences Journal 2010;25(4):206-210
OBJECTIVETo investigate cyclooxygenase-2 (COX-2) expression and its relationship with mismatch repair (MMR) protein expression and microsatellite instability (MSI) in hereditary nonpolyposis colorectal cancer (HNPCC).
METHODSA total of 28 cases of colorectal adenoma and 14 cases of colorectal carcinoma were collected between July 2003 and July 2007 from 33 HNPCC families. Sporadic colorectal adenoma (n=32) and carcinoma patients (n=24) served as controls. With samples of tumor tissues and normal colonic mucosa collected from the patients, the protein expressions of COX-2 and MMR (hMLH1, hMSH2, and hMSH6) were examined with immunohistochemical assay. Frequency of MSI in five standard MSI loci BAT25, BAT26, D2S123, D5S346, and D17S250 were analyzed by means of polymerase chain reaction.
RESULTSThe rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma, respectively. That rate was lower in HNPCC carcinoma than in sporadic carcinoma (Pü0.05). MMR-deletion rate and percentage of high-frequency MSI (MSI-H) in HNPCC carcinoma were higher than those in sporadic colorectal carcinoma [both 71.4% (10/14) vs. 12.5% (3/24), both Pü0.01]. Among the 10 MMR-deficient HNPCC carcinoma patients, COX-2 low-expression was observed in 8 cases (80.0%), while COX-2 high-expression was observed in all of the 4 MMR-positive HNPCC carcinoma cases (Pü0.05). In comparison to MMR positive HNPCC carcinoma, HNPCC adenoma, and sporadic carcinoma, COX-2 expression was significantly lower in corresponding MMR-deficient cases (all Pü0.05). The rates of COX-2 low-expression in HNPCC adenoma, HNPCC carcinoma, and sporadic carcinoma with MSI-H were significantly higher than those in the cases with microsatellite stability (all Pü0.05).
CONCLUSIONCOX-2 is expressed at a low level in HNPCC carcinoma, different from the high COX-2 expression in sporadic carcinoma.
Adult ; Aged ; Base Pair Mismatch ; Base Sequence ; Colorectal Neoplasms, Hereditary Nonpolyposis ; genetics ; Cyclooxygenase 2 ; genetics ; DNA Primers ; DNA Repair ; Female ; Humans ; Immunohistochemistry ; Male ; Microsatellite Repeats ; genetics ; Middle Aged
5.lnfluence of lOL refractive index on straylight level following cataract surgery
Yu-Wei, ZHENG ; Jiang-Yue, ZHAO ; Li-Wei, MA ; Shuang-Ye, CHEN ; Zi-Yan, YU ; Qiu-Han, LI ; Jing, WANG ; Lu, LU ; Jin-Song, ZHANG
International Eye Science 2015;(1):79-82
Abstract?AlM:To investigate the influence of lOL refractive index ( Rl ) on measurement of straylight following cataract surgery.?METHODS:ln this case-control study, 77 eyes of 77 age-related cataract patients who underwent cataract phacoemulsification with posterior chamber aspherical arylic lOL implantation surgery in the Eye Hospital of China Medical University from Aug 2013 to Mar 2014, with a best corrected visual acuity ( BCVA) of 0. 5 or better, were classified into 3 groups randomly using 3 types of lOL: Tecnis ZCB00 Group ( Rl = 1. 47, 22 eyes of 22 subjects); Hoya PY60AD Group ( Rl=1. 52, 24 eyes of 24 subjects);Alcon SN60WF or lQ Group ( Rl=1. 55, 31 eyes of 31 subjects ) . BCVA, pupil size, astigmatism, axial length, intraocular straylight were measured respectively.? RESULTS: Age, axial length, BCVA, pupil size, astigmatism of the three groups were not significant difference (P>0. 05). The straylight of Tecnis, Hoya, lQ group were 1.04±0. 15, 1. 19±0. 14, 1. 14±0. 18. Straylight levels had significant differences among three groups ( F=5. 352, P = 0. 007 < 0. 05 ). There was no significant correlation between BCVA and straylight value (r=-0. 133,P=0. 124>0. 05).?CONCLUSlON:Patients chosen the higher Rl lOL may have a higher straylight level after the surgery.
6.Development and Cytological Study of PNIPAm-Based Nanogels Loaded with Quercetin
Fang-Nan LYU ; Jie HUANG ; Jian-Qiu CHEN ; Zi-Ming ZHAO ; Chao-Ying JIN ; Qian DU
Journal of Nanjing University of Traditional Chinese Medicine 2020;36(2):197-204
OBJECTIVE To improve uptake and cytotoxicity of the drug on MCF-7 cells by developing a poly (N-isopropylacrylamide) (PNIPAm) nanogel for Quercetin (Que) METHODS The PNIPAm nanogel was optimized by an orthogonal design and its structure was confirmed by FT-IR.A single factor experiment was used to optimize the formulation of quercetinloaded nanogel (Que-PNIPAm).The particle size,surface morphology and drug loading were characterized and the in vitro release behavior was investigated.Cytotoxicity of MCF-7 cells induced by Que-PNIPAm was investigated by CCK-8 method.The qualitative and quantitative cellular uptake studies were investigated by fluorescence microscope and flow cytometry,respectively.The mechanism of cellular uptake was investigated by the inhibitor method.RESULTS The particle size and drug loading of Que-PNIPAm were measured as (166.1±2.87)nm and 3.18%,respectively.Nanogel exhibited spherical morphology and uniform size distribution observed by electron microscopy.Compared to free Que,Que-PNIPAm significantly increased inhibition rate of MCF-7 cells.Que-PNIPAm also showed higher cell uptake efficiency and more effective antitumor activity at 42 ℃.Colchicine and 2-deoxyglucose have an inhibitory effect on MCF-7 cells uptake.CONCLUSION The prepared nanogel shows small particle size,thermosensitive property,which could significantly enhance the capacity of cellular uptake and tumor cytotoxicity.The mechanism of cellular uptake demonstrates tubulin is involved in the internalization of the nanogel into MCF-7 cells.
7.Clinical trial of tranexamic acid tablets combined with glutathione and coltagen in patients with chloasma
The Chinese Journal of Clinical Pharmacology 2017;33(6):558-560
Objective To evaluate the clinical efficacy and melisma area severity index (MASI) score of tranexamic acid combined with glutathione,coltagen effect in patients with chloasma.Methods A total of 110 patients with chloasma were randomly divided into control group and treatment group,each group 55 cases.Control group was treated with glutathione combined with collagen patch applying,glutathione injection 1.2 g add 0.9% NaCl or 5% glucose injection 250 mL,intravenous drip,drip speed normal;collagen dressing with 30 min treatment,2 times a week,8 weeks a courses.Treatment group was treated with oral ammonia tranexamic acid tablets 250 mg based on control group,2 times a day,and last for 2 months.Compared the clincial efficacy and MASI score between the two groups.Results The total efficacy in treatment group was 87.27% (48/55),had significant difference with that in control group,which was 69.09% (38/55,P < 0.05).Mter 2,4,6 months,MASI scores in control group were 10.42 ± 3.39,7.94 ± 2.36,6.97 ± 1.30,had significant difference with those in treatment group,which were 9.17 ±2.86,6.38 ±2.87,5.14 ±1.30 (P <0.05).Patients in treatment group had 1 case of nausea,without special treatment,and no adverse drug reactions occurred in control group.Conclusion Tranexamic acid combined with glutathione,collagen paste can obviously improve the chloasma patients with psoriasis area and severity,the curative effect is remarkable.
8.Clinical trial of istretinoin combined with azithromycin on moderate to severe acne occurred after puberty
The Chinese Journal of Clinical Pharmacology 2017;33(16):1519-1522
Objective To explore the clinical efficacy and safety profile of isotretinoin combined with azithromycin in patients with moderate to severe acne occurred after puberty,and the effect of the therapy on sex hormone levels.Methods A total of 120 patients were randomly divided into a control group and combined groups.The control group was given local application of 0.1% adapdene gel,qd.The treatment group was given oral administration of isotretinoin capsules (0.2 mg,qd,at 2 h after meal) and azithromycin granule (0.2 g,qd,continuous treatment for 3 d and then stop for 4 d) on the basis of the control group.Both groups were treated for 4 weeks.The clinical efficacy,efficacy index,and serum sex hormone levels in testosterone,estradiol,progesteron,prolactin (PRL),follicle-stimulating hormone (FSH),luteinizing hormone (LH),sex hormone binding protein (SHBG),dehydroepiandrosterone sulfate (DHEAS) were compared in the two groups.Results After treatment,the total effective rates in treatment group and control group were 96.67% (58/60 cases) and 73.33% (44/60 cases),respectively,and the difference was statistically significant (P <0.01).The efficacy index was 79.68 ± 11.34 in the treatment group and 53.46 ± 14.17 in the control group,with statistically significant difference (P < 0.01).In the treatment group and the control group,the level of serum estradiol were (43.15 ± 14.91),(35.87 ± 18.43) pg · mL-1;the FSH content were (9.23 ± 1.29),(8.95 ±2.21) mU · mL-1;the LH content were (7.81 ±0.32),(5.63 ±0.73) mU · mL-1;the LH/FSH ratio were 0.86 ±0.28 and 0.73 ±0.31;the testosterone content were (1.27 ±0.06),(2.58 ±0.11) nmol · L-1;the progesterone content were (0.95 ± 0.12),(1.19 ± 0.23) ng · mL-1;the PRL content were (10.31 ± 1.17),(14.53 ± 1.09) ng· mL-1;the SHBG content were (51.32 ± 18.71),(69.93 ± 13.65) nmol · L-1;the DHEAS content were (169.85 ±28.41),(183.24 ±29.18) μg ·dL-1,respectively,and these differences were statistically significant (all P < 0.05).The adverse reactions of the treatment group and control group were erythema,scaling,burning,itching and dryness.The incidence of local adverse reactions was 23.33% (14/60 cases) in the treatment group and 18.33% (11/60 cases) in the control group,without statistically significant difference (P < 0.05).Conclusion Isotretinoin combined with azithromycin exerts considerable efficacy by reducing the level of sex hormone and shortening treatment time.
9.Bedside diode laser photocoagulation for 103 cases with serious retinopathy of prematurity in NICU.
Qiu-ping LI ; Zong-hua WANG ; Sheng ZHANG ; Ying CHEN ; Jia CHEN ; Jun-jin HUANG ; Zi-zhen WANG ; Yan KE ; Zhi-chun FENG
Chinese Journal of Pediatrics 2013;51(1):12-15
OBJECTIVETo evaluate the efficacy and safety of the bedside diode laser photocoagulation for severe retinopathy of prematurity in neonatal intensive care unit (NICU).
METHODData of 103 patients with prethreshold or threshold retinopathy of prematurity (ROP), treated with diode laser photoablation after vecuronium-induced anesthesia and mechanical ventilation from March 2009 to July 2011 in NICU of Bayi Children's Hospital.
RESULTTotally 199 eyes in 103 patients received laser therapy with at least 5 months follow up. Among these eyes, zone I disease was found in 76 eyes (38.2%) of 39 infants, zone II disease was found in 123 eyes (61.8%)of 64 infants and additional disease was found in 180 eyes of 91 infants. After treatment 191 (96.0%) of 199 eyes had favorable outcomes and 8 developed to partial retinal detachment. The rate of favorable outcomes in zone I diseases and zone 2 diseases were 89.5% and 100% respectively. The laser therapy was undertaken in all patients safely and the use of ventilator was stopped quickly [after a mean of (6.7 ± 1.3) h].
CONCLUSIONBedside laser photocoagulation in NICU is a safe and effective treatment mode for severe ROP and should be used widely.
Anesthesia ; methods ; Female ; Follow-Up Studies ; Gestational Age ; Humans ; Infant ; Infant, Low Birth Weight ; Infant, Newborn ; Infant, Premature ; Intensive Care Units, Neonatal ; Lasers, Semiconductor ; Light Coagulation ; methods ; Male ; Perioperative Nursing ; Retina ; pathology ; surgery ; Retinopathy of Prematurity ; pathology ; surgery ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome
10.The efficacy and safety in the treatment of chronic abacterial prostatitis/chronic pelvic pain syndrome after intraprostatic injection of Chuanshentong.
Zi-ting LIU ; Hai-qiu LIAO ; Ju-yun YANG ; Luo-yan YANG ; Jin-rui YANG ; Xiao-kun ZHAO ; Ren LIU
National Journal of Andrology 2005;11(9):705-707
OBJECTIVETo assess the clinic efficacy and safety in the treatment of chronic abacterial prostatitis/chronic pelvic pain syndrome (CABP/CPPS) after intraprostatic injection of Chuanshentong.
METHODSFive milliliter of solution blending Chuanshentong and lidocaine was transperineally injected into one lobe of prostate, once a day for 6 days, for a total of 98 cases of patients who had been diagnosed as chronic abacterial prostatitis/chronic pelvic pain syndrome. The efficacy was evaluated by the NIH Chronic Prostatitis Symptom Index (CPSI) after a 12 week follow-up.
RESULTSAll cases had completed the follow-up. Fifty-three cases (54.08%) were completely cured, accompanied by remarkable effective in 17 cases (17.35%) and improved in 23 cases (23.47%). The total remarkable efficacy was 71.43% and improved 94. 90%. Scores of CPSI decreased significantly compared with pre-treatment (95% confidence interval 12.85 approximately 17.91).
CONCLUSIONIt is suggested that transperineally intraprostatic injection of Chuanshentong may be a useful method for the treatment of CABP/CPPS.
Adult ; Chronic Disease ; Drugs, Chinese Herbal ; therapeutic use ; Humans ; Injections, Intralesional ; Male ; Middle Aged ; Pelvic Pain ; drug therapy ; Phytotherapy ; Prostatitis ; drug therapy